[1]
“EPALRESTAT’S PIONEERING ROLE IN EXPANDING HORIZONS FOR DIABETIC NEUROPATHY MANAGEMENT”, ijms, vol. 3, no. 05, pp. 01–04, May 2023, Accessed: Apr. 29, 2026. [Online]. Available: https://www.academicpublishers.org/journals/index.php/ijms/article/view/11